2009
DOI: 10.1590/s1413-86702009000300003
|View full text |Cite
|
Sign up to set email alerts
|

Metallo-β-lactamase-producing Pseudomonas aeruginosa in two hospitals from southern Brazil

Abstract: This study determined the prevalence of metallo-β β β β β-lactamase (MBL)-producing Pseudomonas aeruginosa in two hospitals located in the Southern part of Brazil and compare the performance of two different phenotypic tests. Thirty-one non-repetitive Pseudomonas aeruginosa isolates from various clinical samples from patients admitted to two hospitals located in Rio Grande do Sul, Brazil (twenty-three from a hospital in Porto Alegre City and eight isolates from a hospital in Vale dos Sinos Region). All strains… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
22
0
2

Year Published

2012
2012
2019
2019

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(24 citation statements)
references
References 16 publications
0
22
0
2
Order By: Relevance
“…Resistance to the ␤-lactam antibiotics is frequently observed in the clinical setting and is commonly due to the expression of enzymes that can hydrolyze these compounds, namely, ␤-lactamases (13,(49)(50)(51)(52). P. aeruginosa clinical isolates often harbor acquired ␤-lactamases, particularly those of the oxacillinase type (class D) and the metallo-␤-lactamase IMP and VIM types (class B) (23,25,(53)(54)(55)(56)(57)(58). Chromosomally, P. aeruginosa carries a cephalosporinase, AmpC, that provides intrinsic resistance and that can be expressed at high levels in the presence of ␤-lactams (24, 59, 60) and a carbapenemase, PIB-1, that is reported to be ubiquitous but expressed at low levels in strain PAO1 (26).…”
Section: Resultsmentioning
confidence: 99%
“…Resistance to the ␤-lactam antibiotics is frequently observed in the clinical setting and is commonly due to the expression of enzymes that can hydrolyze these compounds, namely, ␤-lactamases (13,(49)(50)(51)(52). P. aeruginosa clinical isolates often harbor acquired ␤-lactamases, particularly those of the oxacillinase type (class D) and the metallo-␤-lactamase IMP and VIM types (class B) (23,25,(53)(54)(55)(56)(57)(58). Chromosomally, P. aeruginosa carries a cephalosporinase, AmpC, that provides intrinsic resistance and that can be expressed at high levels in the presence of ␤-lactams (24, 59, 60) and a carbapenemase, PIB-1, that is reported to be ubiquitous but expressed at low levels in strain PAO1 (26).…”
Section: Resultsmentioning
confidence: 99%
“…In recent years there has been an increase in carbapenem resistance among Gramnegative bacteria in the Indian subcontinent [12,13,14]. Resistance mechanisms include lack of drug penetration (i.e., porin mutations and efflux pumps) and/or carbapenem hydrolysingbetalactamase enzymes [2,15,16]. Over the past few years MBL producing isolates have emerged worldwide and are associated with outbreaks in health-care settings.…”
Section: Discussionmentioning
confidence: 99%
“…False positive results have been reported in P. aeruginosa as EDTA acts on the membrane of the bacterial cell and increases the cell permeability. Presence of OXA carbapenamases in A. baumannii may also lead to false positive results [7,16]. Hence the results of the MBL phenotypic tests must be interpreted cautiously.…”
Section: Discussionmentioning
confidence: 99%
“…However, despite a resistance rate of just over 25% detected for carbapenems, none of the P. aeruginosa isolates tested were positive for MBL, demonstrating the probable participation of other resistance mechanisms. The isolation rates of MBL-producing P. aeruginosa have widely varied among Brazilian hospitals, with incidences ranging from 3.1% (Wirth et al, 2009) to 35% (Gonçalves et al, 2009. According to Rossi (2011), São Paulo metallo-β-lactamase (SPM) is the most prevalent MBL in Brazilian isolates.…”
Section: Discussionmentioning
confidence: 99%